Idursulfase
Idursulfase, manufactured by Takeda, is a drug used to treat Hunter syndrome. It is a purified form of iduronate-2-sulfatase, a lysosomal enzyme, and is produced by recombinant DNA technology in a human cell line.
It is one of the most expensive drugs ever produced, costing US$567,412 per patient per year.